Header cover image

French Biotech Breakthroughs

Results

1

0 new

Biotech stocks worldwide which are expected to become profitable in the next 3 years.

1 companies

Valneva

Market Cap: €804.1m

A specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs.

VLA

€4.63

7D

13.9%

1Y

26.8%